Keywords: eisai, aricept, receives, japanese, approval, further, efficacy

Eisai's Aricept receives Japanese approval for further efficacy and dosage in severe AD

Article | 03 September 2007

Print This

Japanese drugmaker Eisai has received approval for additional efficacy and dosage of Aricept (donepezil HCl) for the treatment of severe ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in